<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0272170" disease_type="Disease or Syndrome" abbrv="">Shwachman-Diamond syndrome</z:e> (<z:chebi fb="26" ids="8984">SDS</z:chebi>) is an <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> disease caused by mutations in the SBDS gene in approximately 90% of cases </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="26" ids="8984">SDS</z:chebi> is characterized by <z:hpo ids='HP_0001738'>exocrine pancreatic insufficiency</z:hpo> and <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo>, which predisposes to the development of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and/or <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In a new report, the French national cohort studied 102 SDS patients with a median follow-up of 11.6 years, focusing on the natural history of severe cytopenias </plain></SENT>
<SENT sid="3" pm="."><plain>The authors concluded that <z:chebi fb="26" ids="8984">SDS</z:chebi> patients with a young age (&lt;3 months) at first symptomatic presentation or cytopenia at diagnosis were at a high risk of subsequent severe hematological complications (either malignant or nonmalignant) </plain></SENT>
<SENT sid="4" pm="."><plain>Their findings raise the possibility that a clinical algorithm may predict the subsequent development of hematological complications in <z:chebi fb="26" ids="8984">SDS</z:chebi> </plain></SENT>
</text></document>